The combination of sirolimus plus tacrolimus improves outcome after reduced-intensity conditioning, unrelated donor hematopoietic stem cell transplantation compared with cyclosporine plus mycofenolate. [electronic resource]
Producer: 20131211Description: 526-32 p. digitalISSN:- 1592-8721
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Combined Modality Therapy
- Cyclosporine -- administration & dosage
- Disease-Free Survival
- Female
- Gastrointestinal Diseases -- chemically induced
- Graft vs Host Disease -- etiology
- Hematologic Neoplasms -- mortality
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Humans
- Infections -- chemically induced
- Male
- Middle Aged
- Mycophenolic Acid -- administration & dosage
- Prospective Studies
- Sirolimus -- administration & dosage
- Survival Rate
- Tacrolimus -- administration & dosage
- Time Factors
- Transplantation Conditioning -- adverse effects
- Transplantation, Homologous
- Treatment Outcome
- Unrelated Donors
- Young Adult
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.